iThera in the news

iThera Medical’s breakthrough imaging technology is recognized by winning the prestigious “Deutscher Innovationspreis 2014” (German Innovation Award 2014)

April 5, 2014

About

iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research.
OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.

The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.

iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research. OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.

The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.

For further information, please contact:
Christian Wiest
Phone: +49 (0) 89 700 7449-21
Email: christian.wiest@ithera-medical.com